All practice questions

8270 questions

Question 1101Question →

Following a severe industrial accident where he fell approximately three stories, a 51-year-old male worker is evaluated in the trauma bay. He is deeply comatose, exhibiting a Glasgow Coma Scale score of 6. Initial vitals demonstrate a blood pressure of 72/38 mm Hg, a pulse of 142/min, and a respiratory rate of 36/min. During the primary evaluation, the clinician notes tracheal deviation toward the right side and a complete lack of breath sounds on the left. Furthermore, the patient's abdomen is markedly distended with guarding on palpation, and the pelvic ring demonstrates obvious mechanical instability.

Arrange the following interventions in the most appropriate chronological sequence for this patient's acute resuscitation, in accordance with standard trauma protocols.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Endotracheal intubation, 2) Decompression of the left chest, 3) Application of a pelvic binder with blood transfusion, 4) FAST scan, and 5) Transfer to the operating room.
According to standard trauma resuscitation protocols (such as ATLS), trauma management must strictly follow the primary survey sequence to address the most immediately life-threatening injuries first. Airway (A) is the highest priority, requiring endotracheal intubation for a GCS of 6. Breathing (B) follows, requiring immediate decompression of the tension pneumothorax (indicated by absent breath sounds and tracheal deviation). Circulation (C) is next, addressed by mechanical stabilization of the bleeding pelvis and uncrossmatched blood transfusion. Once the ABCs are addressed, diagnostic adjuncts like the FAST scan are performed. Finally, definitive care (exploratory laparotomy) is provided for the intra-abdominal hemorrhage.

Step-by-Step Solution

1
Identify the need for a definitive airway.
Endotracheal intubation is selected as the first step.
The patient has a GCS of 6; trauma protocols strictly prioritize Airway (A) first with cervical spine precautions.
2
Address the immediate respiratory compromise.
Left chest decompression is selected as the second step.
Absent breath sounds and a deviated trachea indicate a tension pneumothorax; Breathing (B) is the second priority.
3
Address the hemorrhagic shock and obvious mechanical bleeding source.
Pelvic binder application and blood transfusion are selected as the third step.
Hypotension and an unstable pelvis indicate severe bleeding; Circulation (C) immediately follows Breathing.
4
Evaluate the distended and rigid abdomen.
A FAST scan is selected as the fourth step.
After the primary ABCs are stabilized, diagnostic adjuncts like FAST help rapidly identify sources of non-compressible intra-abdominal hemorrhage.
5
Determine the definitive management plan.
Transfer to the operating room is selected as the final step.
A hemodynamically unstable patient with a likely positive FAST and rigid abdomen requires emergency exploratory laparotomy.

Key Concept

Advanced Trauma Life Support (ATLS) primary survey sequence for managing multiple life-threatening injuries.
Estimated Time:1m 30s
Question 1102Question →

A 74-year-old woman is brought to the emergency department due to the sudden onset of severe, unremitting abdominal pain that began 2 hours ago. She has a medical history of hypertension, hyperlipidemia, and atrial fibrillation, but has not been taking her prescribed anticoagulant medication. On physical examination, she appears distressed and diaphoretic. Her temperature is 37.1°C, blood pressure is 118/74 mmHg, and heart rate is 112/min and irregularly irregular. Abdominal examination reveals a soft, non-distended abdomen with mild diffuse tenderness but no guarding or rebound tenderness. Bowel sounds are hypoactive. Laboratory studies show a leukocyte count of 18,500/mm³ and a serum lactate of 3.8 mmol/L. Arrange the following management steps in the most appropriate sequential order for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Fluid resuscitation and antibiotics, followed by CT angiography, then laparotomy with embolectomy, followed by resection of necrotic bowel, and finally a planned second-look laparotomy.
The correct management of acute mesenteric ischemia follows a strict protocol to minimize mortality and bowel loss. It begins with resuscitation (fluids/antibiotics) to stabilize the patient, followed by CTA for rapid diagnosis. In the operating room, the absolute rule is to restore perfusion (embolectomy) before assessing tissue viability, ensuring that only irreversibly necrotic bowel is resected. Finally, because borderline tissue may declare itself later, a second-look laparotomy is standard practice.

Step-by-Step Solution

1
Identify the patient's clinical presentation as highly suspicious for acute acute mesenteric ischemia.
The combination of severe pain out of proportion to the physical exam, atrial fibrillation (embolic source), leukocytosis, and elevated lactate points directly to mesenteric ischemia.
Recognizing the life-threatening emergency dictates an immediate, protocol-driven response.
2
Prioritize initial medical stabilization.
Place IV lines, administer crystalloid fluids, and give broad-spectrum antibiotics.
Patients with ischemic bowel rapidly sequester fluids and are at high risk for bacterial translocation and sepsis.
3
Select the appropriate diagnostic imaging.
Order a CT angiography of the abdomen and pelvis.
CTA is highly sensitive and specific for detecting arterial occlusions in the superior mesenteric artery and helps plan the surgical approach.
4
Determine the correct intraoperative sequence.
Perform the embolectomy before resecting any bowel.
Restoring perfusion first allows marginally ischemic bowel to recover, preventing the unnecessary resection of viable tissue and reducing the risk of short bowel syndrome.
5
Plan for postoperative reassessment.
Schedule a second-look laparotomy within 24 to 48 hours.
It is often impossible to definitively determine bowel viability during the initial operation; a second look ensures no necrotic bowel is missed while maximizing bowel preservation.

Key Concept

Management sequence for acute mesenteric ischemia, emphasizing revascularization prior to resection.
Estimated Time:1m 30s
Question 1103Question →

A 32-year-old male is evaluated at the behavioral health center for profound distress. Five months prior, he witnessed a catastrophic scaffolding collapse at his construction site. Since the incident, he suffers from severe hyperarousal, nightly harrowing dreams about the collapse, and active avoidance of any construction zones. He feels emotionally estranged from his spouse. Over the previous six weeks, he has also manifested a severely depressed affect, extreme fatigue, and complete loss of interest in his usual recreational activities.

Review of his psychiatric history reveals an involuntary psychiatric admission at age 23. During that 18-day admission, he exhibited expansive mood, pressured speech, a perceived lack of need for sleep, and auditory hallucinations of a voice declaring him 'the chosen architect.' These hallucinations ceased entirely within days of mood stabilization.

Five days ago, the patient abruptly stopped taking phenelzine—prescribed by a different provider for his low mood—due to his inability to maintain the required dietary restrictions. He is currently taking no medications.

Which of the following represents the most appropriate next step in management?

Show answer & explanation

Answer: Begin lithium and arrange for trauma-focused psychotherapy

Answer

The most appropriate next step is to initiate a mood stabilizer that does not interact with MAOIs (like lithium) and refer the patient for trauma-focused psychotherapy.
The correct management strategy safely addresses this complex patient's multiple psychiatric conditions. He is suffering from Post-Traumatic Stress Disorder (PTSD) and a major depressive episode. However, his history of an 18-day hospitalization for expansive mood, decreased need for sleep, and psychotic features indicates an underlying diagnosis of Bipolar I Disorder. Furthermore, he discontinued phenelzine (an MAOI) only 5 days ago. Because MAOIs irreversibly inhibit monoamine oxidase, starting any serotonergic agent (like an SSRI) within 14 days risks life-threatening serotonin syndrome. Lithium is an effective mood stabilizer for bipolar depression that has no serotonergic interaction with MAOIs, making it safe to initiate immediately. Concurrently, trauma-focused psychotherapy is the first-line, evidence-based treatment for PTSD and carries no pharmacological risks.

Step-by-Step Solution

1
Evaluate the current symptom profile against DSM-5 criteria.
The patient meets criteria for Post-Traumatic Stress Disorder (PTSD) and is currently experiencing a major depressive episode.
Establishing the current acute diagnoses identifies the primary targets for immediate treatment.
2
Analyze the past psychiatric history.
The prior 18-day hospitalization for expansive mood, decreased sleep, and hallucinations that resolved with mood stabilization confirms an underlying diagnosis of Bipolar I Disorder with psychotic features.
A history of mania fundamentally alters the pharmacological management of current depressive or anxiety symptoms.
3
Assess the pharmacological constraints imposed by recent medication use.
The patient discontinued phenelzine (an MAOI) 5 days ago. A strict 14-day washout period is required before starting any serotonergic medications.
MAOIs irreversibly inhibit monoamine oxidase; combining them (or starting serotonergic drugs before enzyme regeneration) causes life-threatening serotonin syndrome.
4
Select a safe and effective management plan that addresses all constraints.
Begin lithium and arrange for trauma-focused psychotherapy.
Lithium treats bipolar depression without serotonin syndrome risk, and trauma-focused psychotherapy is the first-line, non-pharmacological treatment for PTSD.

Key Concept

Complex management of PTSD and bipolar depression in the context of recent MAOI discontinuation.

Alternative Method

If lithium is contraindicated (e.g., due to severe renal impairment), valproate or an atypical antipsychotic approved for bipolar depression (such as quetiapine or lurasidone) could be initiated instead, as they also do not carry a risk of serotonin syndrome.
Estimated Time:2m 30s
Question 1104Question →

On his sixth day of recovery following an open appendectomy for perforated appendicitis, a 65-year-old man reports progressive abdominal bloating and bilious vomiting. He has not passed flatus or stool for the past 48 hours. Vital signs show a heart rate of 110/min and blood pressure of 115/75 mmHg. Physical examination reveals a markedly distended, tympanitic abdomen with high-pitched 'tinkling' bowel sounds. There is diffuse mild tenderness but no rebound or guarding. Arrange the following management steps in the most appropriate chronological sequence for this patient's condition, progressing from initial intervention to definitive management.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Initiate NPO and IV fluids, 2) Place a nasogastric tube, 3) Obtain a CT scan of the abdomen, and 4) Proceed with an exploratory laparotomy.
The management of an uncomplicated early postoperative small bowel obstruction follows a well-defined progression of care. Initial management focuses on stabilizing the patient by making them NPO and providing intravenous fluid resuscitation to combat hypovolemia from third-spacing. This is immediately followed by nasogastric tube placement to decompress the stomach and prevent aspiration. Once stabilized, a CT scan is obtained to confirm the diagnosis, identify the transition point, and rule out complications like strangulation. Surgical intervention (exploratory laparotomy) is reserved as the final step if conservative management fails after several days or if the patient develops signs of ischemia or peritonitis.

Step-by-Step Solution

1
Recognize the clinical presentation of an early postoperative small bowel obstruction.
The patient's obstipation, vomiting, distension, and high-pitched bowel sounds confirm the suspected diagnosis.
Accurate identification dictates the subsequent algorithmic management.
2
Prioritize initial stabilization with NPO status and IV fluids.
Intravascular volume is restored and further gastrointestinal input is halted.
Third-spacing of fluids into the bowel lumen leads to significant hypovolemia that must be corrected immediately.
3
Implement mechanical decompression via a nasogastric tube.
Gastric contents and swallowed air are evacuated.
This reduces the risk of aspiration and alleviates patient discomfort.
4
Acquire diagnostic imaging to stratify risk and guide definitive therapy.
A CT scan provides visualization of the bowel wall and transition point.
Imaging differentiates a partial obstruction (which may resolve conservatively) from a complete obstruction or ischemia.
5
Reserve surgical exploration for definitive failure of conservative therapy.
Laparotomy is performed only after conservative measures are exhausted or if complications arise.
Many early postoperative bowel obstructions resolve with supportive care alone; surgery is the final step in the algorithmic pathway.

Key Concept

Stepwise management of early postoperative small bowel obstruction
Estimated Time:1m 0s
Question 1105Question →

You are evaluating five different patients who have recently initiated psychotropic medications. Each patient is now presenting with a specific adverse effect based on their history and examination findings. Which primary pharmacological mechanism best corresponds to the responsible medication for each patient's clinical presentation?

Click a left item, then click its matching right item

Items

A 32-year-old woman with bulimia nervosa and normal vital signs presents with postictal confusion following a generalized tonic-clonic seizure shortly after starting a new antidepressant.
A 45-year-old man with depression and severe insomnia presents in acute distress with a painful, sustained penile erection lasting 6 hours after taking a newly prescribed sleep aid.
A 29-year-old woman with treatment-resistant depression presents with diaphoresis, severe anxiety on mental status exam, and a blood pressure of 220/115 mm Hg after attending a wine and aged cheese tasting.
A 55-year-old man with major depressive disorder and diabetic neuropathy presents with a euthymic mood but new-onset resting hypertension (155/95 mm Hg) following a dose increase of his medication.
A 24-year-old man treated for depression presents with significant recent weight gain (5 kg) and complains of profound daytime sedation and dizziness upon standing (orthostatic hypotension).

Matches

Show answer & explanation

Answer

Match each clinical presentation to the underlying mechanism of action of the responsible psychotropic medication: 1-Bupropion, 2-Trazodone, 3-MAOI, 4-SNRI, 5-Mirtazapine.
Bupropion causes seizures in patients with eating disorders due to NE/DA reuptake inhibition. Trazodone causes priapism via alpha-1 antagonism. MAOIs cause tyramine hypertensive crisis by inhibiting monoamine oxidase. SNRIs like venlafaxine cause dose-dependent hypertension via NE reuptake inhibition. Mirtazapine causes sedation, weight gain, and orthostasis via H1 and alpha-1/alpha-2 antagonism.

Step-by-Step Solution

1
Analyze each clinical vignette to identify the specific psychotropic medication based on the unique adverse effect profile and the patient's history.
Identified medications: Bupropion (Left 1), Trazodone (Left 2), MAOI (Left 3), Venlafaxine/SNRI (Left 4), Mirtazapine (Left 5).
Recognizing the classic clinical presentation of drug-specific side effects is required before determining the mechanism of action.
2
Determine the pharmacological mechanism of action for each identified medication.
Bupropion inhibits NE/DA reuptake. Trazodone inhibits serotonin reuptake and blocks alpha-1 receptors. MAOIs irreversibly inhibit monoamine oxidase. Venlafaxine inhibits serotonin and dose-dependently inhibits NE reuptake. Mirtazapine blocks alpha-2 and H1 receptors.
Understanding the receptor-level activity explains why these specific adverse effects occur in these clinical scenarios.
3
Map the identified mechanism of action to the corresponding right item for each patient scenario.
All 5 pairs are successfully matched according to their pharmacological profiles.
This completes the matching process by synthesizing clinical diagnostics with neuropharmacology.

Key Concept

The mechanisms of action of psychotropic medications directly correlate with their unique and potentially dangerous adverse effect profiles.
Question 1106Question →

A 54-year-old postmenopausal woman comes to the clinic due to a 3-month history of an itchy, flaking rash on her left nipple and areola. She states that the rash initially began as a small red patch but has gradually spread and thickened. She applied an over-the-counter hydrocortisone cream twice daily for 4 weeks with no improvement. She has no personal or family history of breast cancer. On physical examination, there is a unilateral, well-demarcated, erythematous, scaly plaque confined to the left nipple-areolar complex with small areas of superficial crusting and ulceration. The nipple appears slightly flattened. Palpation of the left breast yields no distinct masses. Axillary lymph nodes are not palpable. Bilateral diagnostic mammography reveals no abnormalities. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Punch biopsy of the skin lesion

Answer

Punch biopsy of the skin lesion is the most appropriate next step to diagnose suspected Paget disease of the breast.
This patient presents with a unilateral, pruritic, scaly, and crusting erythematous plaque on the nipple-areolar complex that is refractory to low-potency topical corticosteroids. This presentation is highly suspicious for Paget disease of the breast, a rare malignancy characterized by the migration of malignant glandular cells (Paget cells) through the lactiferous ducts to the nipple epidermis. The most appropriate next step in management is a full-thickness skin biopsy (such as a punch biopsy) of the affected area to establish a histopathologic diagnosis. Even with a negative mammogram and no palpable mass, biopsy is mandatory because a significant percentage of patients with Paget disease have an underlying ductal carcinoma in situ (DCIS) or invasive carcinoma that is occult on mammography.

Step-by-Step Solution

1
Identify the key clinical features
Unilateral, persistent, pruritic and scaling nipple rash in a postmenopausal woman that is refractory to topical corticosteroids.
Differentiates malignant from benign etiology.
2
Determine the most likely diagnosis
Paget disease of the breast.
The failure of empirical treatment for a unilateral eczema-like lesion points toward a neoplastic process involving the nipple epidermis.
3
Select the most appropriate diagnostic test
Punch biopsy of the affected skin.
A full-thickness skin biopsy is required to identify intraepidermal Paget cells and establish the diagnosis, regardless of mammography findings.

Key Concept

Diagnosis of Paget disease of the breast requires a full-thickness skin biopsy (e.g., punch biopsy) of the affected nipple-areolar complex, especially when conservative therapy fails.
Estimated Time:1m 30s
Question 1107Question →

A 25-year-old woman is brought to the outpatient psychiatric clinic by her sister due to a 4-week history of profound sadness, lack of motivation, and sleeping up to 14 hours daily. For the past week, the patient has been hearing an unfamiliar voice repeatedly telling her she is "hopeless and already dead." Her past psychiatric history is notable for a 3-week hospitalization two years ago when she exhibited extremely rapid speech, required only two hours of sleep per night, and harbored grandiose delusions about being a spiritual prophet. Following her discharge from that hospitalization, she returned to her baseline functioning and experienced no mood or psychotic symptoms until the current episode. The patient currently takes no medications. Vital signs are within normal limits. Laboratory evaluation reveals a thyroid-stimulating hormone (TSH) level of 1.4μU/mL1.4 \mu U/mL (normal: 0.5−5.0μU/mL0.5-5.0 \mu U/mL) and a free thyroxine (T4) level of 0.8ng/dL0.8 ng/dL (normal: 0.9−1.7ng/dL0.9-1.7 ng/dL). Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Initiate quetiapine

Answer

Initiate quetiapine
The patient has a history of a distinct manic episode (decreased need for sleep, grandiose delusions, severe impairment requiring hospitalization), which establishes a diagnosis of Bipolar I Disorder. She is currently experiencing an acute major depressive episode with mood-congruent psychotic features. The most appropriate treatment for acute bipolar depression includes agents like quetiapine, lurasidone, or cariprazine. Quetiapine is particularly appropriate here as it is a second-generation antipsychotic that effectively treats bipolar depression while also addressing the patient's acute psychotic symptoms (auditory hallucinations).

Step-by-Step Solution

1
Analyze the patient's psychiatric history.
The history of a manic episode with grandiose delusions two years ago establishes a diagnosis of Bipolar I Disorder.
A single manic episode is sufficient to diagnose Bipolar I Disorder, which dictates all future pharmacological management of mood episodes.
2
Evaluate the current clinical presentation.
The patient is experiencing a severe major depressive episode with mood-congruent psychotic features (hearing voices saying she is dead).
Identifying the current phase of the bipolar illness (acute depression with psychosis) is necessary to select an agent that targets both mood and psychosis.
3
Interpret the laboratory findings.
The normal TSH with a borderline low Free T4 rules out primary hypothyroidism as the cause of her severe depression.
Medical causes of depressive symptoms must be ruled out, but misinterpreting minor lab variations can lead to inappropriate treatment.
4
Select the most appropriate pharmacotherapy.
Quetiapine is selected as it is FDA-approved for bipolar depression and possesses antipsychotic properties.
Standard antidepressants (SSRIs) are contraindicated as monotherapy in Bipolar I due to the risk of manic switch, and the patient requires an agent that treats both depression and psychosis.

Key Concept

Management of acute bipolar depression with psychotic features involves avoiding antidepressant monotherapy and utilizing an atypical antipsychotic like quetiapine or lurasidone.
Question 1108Question →

During morning rounds on a surgical ward, an internal medicine consultant is asked to evaluate a patient recovering from a right femoral neck fracture repair performed 48 hours ago. The nursing staff reports that the patient was awake, alert, and conversational yesterday, but overnight she became highly agitated, attempted to remove her urinary catheter, and claimed that insects were crawling on her bed sheets. The patient's daughter confirms her mother lived independently and had no history of memory issues or psychiatric illness prior to the fall. Physical examination reveals an inattentive patient who drifts off to sleep during questioning. Vital signs are stable, and a basic metabolic panel is unremarkable. Which of the following is the most likely diagnosis for this patient's acute presentation?

Show answer & explanation

Answer: Delirium

Answer

Delirium
The correct answer is delirium. This patient presents with an acute change in mental status, marked inattention (drifting off during questioning), a fluctuating level of consciousness, and visual hallucinations (seeing insects) following a major surgery. These features, combined with a lack of prior cognitive impairment, are the classic clinical hallmarks of delirium. Delirium is a neurocognitive disorder that is typically secondary to an underlying medical condition, medication effect, infection, or the physiological stress of surgery.

Step-by-Step Solution

1
Identify the timeline and onset of the patient's symptoms.
The patient developed acute behavioral changes and hallucinations over a matter of hours (overnight) on postoperative day 2.
Establishing the timeline helps distinguish acute conditions from chronic neurodegenerative diseases.
2
Analyze the specific clinical features present on examination.
The patient exhibits marked inattention, a fluctuating level of consciousness (drifting off to sleep), and visual hallucinations (seeing insects).
These specific signs are hallmark diagnostic features of a specific acute cognitive disorder.
3
Synthesize the findings to determine the most likely diagnosis.
An acute, fluctuating change in mental status with inattention in a hospitalized patient points directly to a secondary physiological effect rather than a primary psychiatric disorder.
Ruling out primary psychiatric illnesses and chronic cognitive decline confirms the diagnosis of delirium.

Key Concept

Clinical presentation and diagnostic criteria for delirium
Estimated Time:1m 0s
Question 1109Question →

A 22-year-old college student presents to the university outpatient clinic reporting a 5-week history of feeling profoundly sad, crying frequently, and lacking the motivation to attend her classes. She reports sleeping up to 12 hours a day and eating significantly more than usual, resulting in a 4 kg (8.8 lb) weight gain. She has no significant past medical history, and her vital signs are within normal limits. Laboratory tests, including a complete blood count and thyroid-stimulating hormone (TSH) level, are normal. She currently takes no medications or illicit substances. The physician suspects a major depressive episode and plans to prescribe fluoxetine. Which of the following is the most appropriate next step in the clinical evaluation and management of this patient?

Show answer & explanation

Answer: Inquire about any past periods of persistently elevated mood, grandiosity, and decreased need for sleep

Answer

Inquire about any past periods of persistently elevated mood, grandiosity, and decreased need for sleep
The correct next step is to screen for a history of manic or hypomanic episodes. This patient presents with a major depressive episode characterized by atypical features (hypersomnia, weight gain). Before initiating antidepressant monotherapy (e.g., fluoxetine), it is absolutely critical to rule out a history of bipolar disorder. Prescribing an antidepressant to a patient with unrecognized bipolar disorder can precipitate a manic or hypomanic episode (manic switch). Therefore, specifically asking about periods of persistently elevated mood, impulsivity, and decreased need for sleep is mandatory.

Step-by-Step Solution

1
Identify the patient's primary syndrome
The patient meets criteria for a major depressive episode with atypical features (hypersomnia, hyperphagia, leaden paralysis or weight gain).
Establishing the current episode is necessary before determining the treatment plan.
2
Evaluate the planned pharmacological intervention
The physician plans to prescribe an SSRI (fluoxetine).
Antidepressant monotherapy is the standard treatment for unipolar major depressive disorder.
3
Determine the critical prerequisite before initiating an antidepressant
A lifetime history of mania or hypomania must be ruled out.
If the patient has an undiagnosed history of mania or hypomania (Bipolar I or II disorder), SSRI monotherapy can precipitate a manic switch or rapid cycling. Therefore, screening for these symptoms is the most appropriate next step.

Key Concept

All patients presenting with a major depressive episode must be screened for a history of manic or hypomanic episodes before initiating antidepressant monotherapy to avoid precipitating a manic switch.
Question 1110Question →

An unmarried 29-year-old accountant is referred for a psychiatric evaluation by his corporate human resources department due to ongoing interpersonal difficulties. For the past seven years, he has worked in an isolated cubicle and consistently refuses to attend team meetings or company events. During the clinical interview, the patient sits rigidly, avoids eye contact, and appears visibly apprehensive. He explains that he avoids his colleagues because he is convinced they are harboring malicious intentions and secretly sabotaging his energy fields. He notes that this intense anxiety persists even with colleagues he has known for years. He describes his mind as being 'tuned to a specialized frequency that intercepts cosmic warnings.' His speech is markedly abstract and circumstantial, yet it remains goal-directed without derailment or neologisms. He firmly denies ever experiencing auditory or visual hallucinations. A review of his medical history reveals that these eccentric behaviors and beliefs have been present continuously since his late teens, without distinct episodes of clinical deterioration or full recovery. He denies any periods of pervasive sadness or elevated mood. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Schizotypal personality disorder

Answer

Schizotypal personality disorder
The correct diagnosis is Schizotypal personality disorder. This condition is a Cluster A personality disorder characterized by a pervasive pattern of social and interpersonal deficits, accompanied by cognitive or perceptual distortions and eccentricities of behavior. The patient's belief in 'cosmic warnings' (magical thinking), intense fear of colleagues' malicious intentions (paranoid social anxiety), odd and circumstantial speech, and lack of close relationships perfectly align with this diagnosis. Crucially, these traits have been present continuously since late adolescence without the emergence of frank delusions, true hallucinations, or gross disorganization, effectively ruling out primary psychotic disorders.

Step-by-Step Solution

1
Analyze the patient's timeline and illness trajectory.
The patient has experienced stable, continuous symptoms since his late teens (over 7 years) without episodic deterioration or recovery.
Establishing chronicity helps rule out acute or episodic psychiatric conditions such as brief psychotic disorder and schizophreniform disorder.
2
Evaluate the specific psychiatric symptoms presented.
The patient exhibits magical thinking ('cosmic warnings'), paranoid social anxiety that does not diminish with familiarity, eccentric behavior, and circumstantial speech, but denies frank hallucinations and lacks disorganized thought.
Differentiating between eccentric personality traits (magical thinking, ideas of reference) and frank psychotic symptoms (fixed delusions, hallucinations) is necessary to rule out schizophrenia.
3
Synthesize the findings to determine the most accurate diagnosis.
The combination of lifelong social isolation, odd beliefs, perceptual distortions, and paranoid anxiety without true psychosis firmly establishes a Cluster A personality disorder diagnosis.
The diagnostic criteria for Schizotypal Personality Disorder perfectly encompass the patient's pervasive pattern of eccentricities and interpersonal deficits.

Key Concept

Schizotypal personality disorder is differentiated from schizophrenia spectrum disorders by its lifelong, pervasive pattern of eccentric behavior, magical thinking, and paranoid social anxiety, without the presence of frank delusions, hallucinations, or formal thought disorder.
Question 1111Question →

A 35-year-old teacher visits her primary care physician due to chronic fatigue and neck pain. During the interview, she reveals that she feels constantly 'on edge' and struggles to control her worries. Over the last 7 months, she has experienced relentless anxiety concerning her family's health, financial stability, and school responsibilities, despite no recent changes in her life circumstances. She notes that these thoughts frequently prevent her from falling asleep. Physical examination is unremarkable, and recent laboratory studies, including thyroid-stimulating hormone levels, are within normal limits. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Generalized anxiety disorder

Answer

Generalized anxiety disorder
The patient's presentation of excessive, uncontrollable worry about multiple issues (health, finances, work) lasting for at least 6 months, along with somatic symptoms (muscle tension, fatigue, sleep disturbance), perfectly aligns with the DSM-5 criteria for generalized anxiety disorder (GAD). The normal TSH levels appropriately rule out hyperthyroidism, a common medical mimic.

Step-by-Step Solution

1
Analyze the primary symptoms and their duration.
The patient has excessive, uncontrollable worry about multiple everyday domains (family, finances, work) lasting for 7 months.
Duration is a critical diagnostic criterion for psychiatric disorders; greater than 6 months of excessive worry points toward generalized anxiety disorder.
2
Identify accompanying somatic symptoms.
The patient experiences chronic fatigue, neck pain (muscle tension), feeling 'on edge', and sleep disturbance.
Generalized anxiety disorder requires the presence of at least three associated somatic or cognitive symptoms, such as restlessness, fatigue, difficulty concentrating, irritability, muscle tension, or sleep disturbance.
3
Rule out other potential causes.
Normal physical exam and TSH levels rule out hyperthyroidism. The absence of a specific stressor, panic attacks, or trauma rules out adjustment disorder, panic disorder, and acute stress disorder.
Psychiatric diagnoses are made after ensuring symptoms are not better explained by another medical condition, substance, or mental disorder.

Key Concept

Generalized anxiety disorder is characterized by excessive, difficult-to-control worry about multiple everyday issues lasting for at least 6 months, accompanied by somatic symptoms like muscle tension, fatigue, and sleep disturbance.
Question 1112Question →

A 26-year-old woman is brought to the clinic by her sister due to a 5-week history of severe depression. The patient describes her mood as "bottomless" and complains that her arms and legs constantly feel "heavy as lead." She reports sleeping 14 to 16 hours daily and has gained 6 kg (13.2 lb) over the past month, which she attributes to intense carbohydrate cravings. Despite her profound sadness, the sister notes that the patient's mood brightened considerably yesterday when she was presented with a surprise gift, though she relapsed into despondency hours later. The patient has experienced two similar depressive episodes in the past. The sister confidentially shares that during the patient's sophomore year of college, there was a distinct 10-day period where she seemed "like a completely different person." During that time, she slept only 3 hours a night without feeling fatigued, rapidly repainted her entire apartment, and abruptly spent her tuition money on a business venture that never materialized. She has no significant past medical history. Physical examination is unremarkable. Which of the following is the most appropriate next step in pharmacotherapy for this patient?

Show answer & explanation

Answer: Initiate quetiapine

Answer

Initiate quetiapine
The correct answer is to initiate quetiapine. This patient is currently experiencing a major depressive episode characterized by atypical features, which include mood reactivity (brightening in response to positive events), hypersomnia, weight gain/hyperphagia, and leaden paralysis (heavy feeling in limbs). Crucially, her history reveals a distinct 10-day period of decreased need for sleep, increased goal-directed activity, and impulsivity. Because this elevated state lasted longer than 4 days and did not result in severe functional impairment or require hospitalization, it meets the criteria for a hypomanic episode. A history of at least one major depressive episode and at least one hypomanic episode establishes the diagnosis of Bipolar II disorder. For the acute treatment of bipolar depression, first-line pharmacotherapy includes specific atypical antipsychotics such as quetiapine, lurasidone, or cariprazine.

Step-by-Step Solution

1
Identify the features of the current depressive episode.
The patient has leaden paralysis, hypersomnia, weight gain, and mood reactivity.
These specifically meet the DSM-5 criteria for a major depressive episode with atypical features.
2
Evaluate the patient's psychiatric history for periods of elevated mood.
The history reveals a 10-day period of decreased need for sleep, increased goal-directed activity, and impulsivity without severe impairment requiring hospitalization.
This establishes a history of a past hypomanic episode, which changes the primary diagnosis from Major Depressive Disorder to Bipolar II disorder.
3
Determine the appropriate pharmacotherapy for acute Bipolar II depression.
First-line agents include quetiapine, lurasidone, or cariprazine. Antidepressant monotherapy must be avoided.
Antidepressants can precipitate a manic or hypomanic switch in patients with bipolar disorder.

Key Concept

Bipolar II Disorder presenting as acute depression with atypical features
Question 1113Question →

A 29-year-old woman presents to the clinic 4 weeks postpartum for a follow-up evaluation. She reports feeling profoundly sad, tearful, and unable to enjoy time with her newborn. She states, "I feel completely overwhelmed and guilty for being a terrible mother." She wakes up at 3:00 AM every day and is unable to fall back asleep, despite her husband handling the nighttime feedings. She has a poor appetite and has lost 4.5 kg (10 lb) since her delivery. She denies any thoughts of harming herself or her infant. She had an uncomplicated vaginal delivery but required a second-degree perineal laceration repair; she takes tramadol occasionally for residual pain. When reviewing her psychiatric history, she mentions that during her sophomore year of college, she experienced a distinct 5-day period where she felt "invincible," required only 2 hours of sleep per night, and started three different student organizations while speaking so rapidly her friends could hardly understand her. This college episode resolved spontaneously without hospitalization. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Initiate quetiapine

Answer

Initiate quetiapine
This patient is experiencing a major depressive episode (depressed mood, anhedonia, sleep disturbance, weight loss, severe guilt) with peripartum onset. Crucially, her history of a 5-day period of elevated mood, decreased need for sleep, pressured speech, and increased goal-directed activity without hospitalization meets the criteria for a hypomanic episode. Therefore, her correct diagnosis is Bipolar II disorder. In patients with bipolar depression, monotherapy with standard antidepressants (such as SSRIs) is contraindicated because it can precipitate a hypomanic or manic switch. First-line evidence-based treatments for bipolar depression include certain atypical antipsychotics (e.g., quetiapine, lurasidone, cariprazine) or mood stabilizers. Quetiapine is an excellent choice for this patient, as it treats bipolar depression effectively and is frequently used during the postpartum period due to its well-established safety profile.

Step-by-Step Solution

1
Evaluate the current mood episode based on the patient's presenting symptoms.
The patient presents with severe sadness, anhedonia, early morning awakening, weight loss, and guilt lasting 4 weeks postpartum, which meets the criteria for a major depressive episode with peripartum onset.
To establish the current clinical problem requiring intervention.
2
Analyze the patient's psychiatric history for prior mood episodes.
The patient describes a past 5-day episode of elevated mood, decreased need for sleep, increased goal-directed activity, and pressured speech that resolved without hospitalization, which meets the criteria for a hypomanic episode.
To differentiate between unipolar depression and bipolar depression, which fundamentally alters the treatment approach.
3
Synthesize the current and past history to determine the correct diagnosis.
A history of at least one hypomanic episode and at least one major depressive episode indicates a diagnosis of Bipolar II disorder.
To guide the selection of appropriate pharmacotherapy and avoid contraindicated agents.
4
Select the most appropriate pharmacotherapy for the patient's diagnosis.
First-line treatment for bipolar depression includes atypical antipsychotics such as quetiapine or lurasidone, which treat depression without the risk of inducing a manic switch.
To provide safe and effective management while avoiding contraindicated medications like antidepressant monotherapy.

Key Concept

Patients presenting with a major depressive episode must be carefully screened for a history of mania or hypomania. If a history is present (indicating bipolar disorder), antidepressant monotherapy is contraindicated due to the risk of mood switch, and treatments like quetiapine or lurasidone are preferred.
Estimated Time:1m 30s
Question 1114Question →

A 2626-year-old woman comes to the psychiatric clinic for a follow-up evaluation regarding persistent low mood, hypersomnia, and severe fatigue. She has an established diagnosis of bipolar II disorder. Six weeks ago, she began taking lamotrigine for a major depressive episode. Her dosage was gradually increased according to standard protocols to a maintenance dose of 200 mg200 \text{ mg} daily, which she has been taking consistently for the past 22 weeks. Despite medication adherence, the patient states she feels "just as depressed as before" and struggles to complete basic daily tasks. Her medical history is notable for polycystic ovary syndrome, which is well-controlled with a combined ethinyl estradiol and norgestimate oral contraceptive pill. Vital signs are within normal limits. Laboratory testing reveals a serum lamotrigine concentration of 1.2μg/mL1.2 \mu\text{g/mL} (therapeutic reference range: 3−15μg/mL3-15 \mu\text{g/mL}).

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Increase the dosage of lamotrigine

Answer

Increase the dosage of lamotrigine
The correct intervention is to increase the dosage of lamotrigine. Lamotrigine is primarily metabolized in the liver via glucuronidation by the enzyme UDP-glucuronosyltransferase 1A4 (UGT1A4). Estrogen, a key component of combined oral contraceptive pills, is a potent inducer of UGT1A4. This enzymatic induction significantly accelerates the clearance of lamotrigine, often reducing serum concentrations by 50%50\% or more. Because this patient is symptomatic and has a confirmed subtherapeutic lamotrigine level resulting from this known pharmacokinetic interaction, the appropriate clinical step is to increase the lamotrigine dosage to achieve therapeutic efficacy. Often, female patients taking concurrent estrogen-containing contraceptives require up to double the standard maintenance dose of lamotrigine.

Step-by-Step Solution

1
Identify the primary clinical problem.
The patient has bipolar II depression and is symptomatic despite taking a standard maintenance dose of lamotrigine, with objective laboratory evidence of a subtherapeutic drug concentration.
Establishing the baseline clinical status is necessary to determine if the current regimen is adequate.
2
Analyze the patient's medication list for potential pharmacokinetic interactions.
The patient is taking a combined oral contraceptive pill containing ethinyl estradiol.
Drug-drug interactions are a primary cause of subtherapeutic medication levels in psychiatry, particularly with mood stabilizers.
3
Determine the mechanism of the drug-drug interaction.
Estrogen is a potent inducer of UDP-glucuronosyltransferase 1A4 (UGT1A4), the primary hepatic enzyme responsible for the glucuronidation and clearance of lamotrigine.
Understanding this metabolic pathway explains why the lamotrigine level is significantly lower than expected for a compliant patient on a 200 mg200 \text{ mg} dose.
4
Select the safest and most effective clinical intervention.
The lamotrigine dosage must be increased to overcome the accelerated clearance and achieve a therapeutic serum level.
Adjusting the dose addresses the underlying pharmacokinetic issue without abandoning an effective first-line treatment or precipitating dangerous withdrawal toxicities.

Key Concept

Estrogen-containing oral contraceptives induce the glucuronidation (via UGT1A4) of lamotrigine, significantly decreasing its serum concentration and requiring a higher maintenance dose.
Estimated Time:1m 30s
Question 1115Question →

A 24-year-old woman comes to the office after discovering a lump in her right breast while showering 3 days ago. She has not noticed any nipple discharge, skin changes, or breast pain. Her menstrual periods occur every 28 days and last for 4 to 5 days. Her last menstrual period ended 2 weeks ago. Her medical history is unremarkable, and she takes no medications. She has no family history of breast or ovarian cancer. Vital signs are within normal limits. On physical examination, there is a 2.5-cm, firm, mobile, non-tender, well-circumscribed mass in the upper outer quadrant of the right breast. There is no overlying skin erythema, dimpling, or nipple retraction. No axillary or supraclavicular lymphadenopathy is appreciated. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Targeted ultrasound of the right breast

Answer

Targeted ultrasound of the right breast
The correct approach for a new palpable breast mass in a woman younger than 30 years is to perform a targeted ultrasound. Ultrasound is the preferred initial imaging modality in this age group because young women typically have dense breast tissue, which significantly decreases the sensitivity of mammography. Ultrasound can reliably differentiate between solid masses (e.g., fibroadenomas, carcinomas) and fluid-filled simple cysts. If the ultrasound confirms a benign-appearing solid mass (like a fibroadenoma), the patient may then be managed with short-term follow-up or a core needle biopsy based on patient preference and specific ultrasound features.

Step-by-Step Solution

1
Identify the patient's age and clinical presentation.
The patient is a 24-year-old female with a new, distinct, palpable breast mass.
Age is the primary determinant for the initial choice of imaging modality in the diagnostic workup of breast masses.
2
Determine the appropriate initial diagnostic modality based on age.
For women younger than 30 years, targeted ultrasound is indicated.
Younger women have denser breast tissue, which makes mammography less sensitive. Ultrasound effectively differentiates solid masses from fluid-filled cysts.
3
Rule out premature or inappropriate interventions.
Biopsy, mammography, and simple reassurance without imaging are rejected.
Imaging must precede invasive tissue sampling, mammography is reserved for older patients initially, and all new palpable masses require at least baseline imaging evaluation.

Key Concept

Age-based diagnostic pathways for palpable breast masses
Question 1116Question →

A 22-year-old man is brought to the psychiatrist by his parents due to ongoing behavioral changes. Six weeks ago, the patient was hospitalized in the psychiatric unit for 4 days after presenting with severe agitation, auditory hallucinations, and paranoid delusions about being monitored by the government. At that time, his urine toxicology screen was markedly positive for amphetamines. He was discharged after brief treatment with haloperidol. His parents report that since discharge, he has lived at home and has been completely abstinent from all illicit drugs, a claim corroborated by weekly negative urine toxicology screens over the past 5 weeks. Despite his abstinence, the patient continues to experience daily auditory hallucinations of voices conversing about him and firmly believes his neighbors are tracking his movements. He has no prior psychiatric history, and there is no family history of psychiatric illness. His mood is described as 'fine,' and he exhibits no depressive or manic symptoms. Vital signs and physical examination are unremarkable. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Schizophreniform disorder

Answer

Schizophreniform disorder
The correct diagnosis is schizophreniform disorder. While this patient's initial psychotic episode was undoubtedly triggered by amphetamine intoxication, his psychotic symptoms have persisted for 5 weeks despite documented, complete abstinence. According to DSM-5 criteria, if psychotic symptoms persist for more than 1 month after the cessation of acute substance intoxication or withdrawal, the condition must be reclassified as an independent, primary psychotic disorder rather than a substance-induced disorder. Because the patient's total duration of continuous illness is 6 weeks, the correct diagnosis is schizophreniform disorder. The timeline for schizophreniform disorder is defined as symptomatic manifestation lasting at least 1 month but less than 6 months.

Step-by-Step Solution

1
Determine the temporal relationship between the patient's substance use and his psychotic symptoms.
The psychotic symptoms began in the context of acute amphetamine use but have persisted for 5 weeks despite verified abstinence.
According to DSM-5 criteria, a substance-induced psychotic disorder usually resolves within 1 month of substance cessation. Persistence beyond 1 month indicates an independent, primary psychotic disorder.
2
Calculate the total duration of the continuous psychotic episode.
The patient has experienced continuous psychotic symptoms (hallucinations and delusions) for a total of 6 weeks.
The total duration of symptoms is required to accurately differentiate among the primary psychotic disorders.
3
Classify the primary psychotic disorder based on the 6-week timeframe.
The 6-week duration falls in the 1-to-6 month window, making schizophreniform disorder the correct diagnosis.
Brief psychotic disorder is diagnosed for episodes lasting less than 1 month, whereas schizophrenia requires a duration of 6 months or longer.

Key Concept

Psychotic symptoms that persist for greater than 1 month after the cessation of substance use or withdrawal should be considered an independent primary psychotic disorder, requiring chronological classification (e.g., schizophreniform disorder for a 1-to-6 month duration).
Question 1117Question →

A 28-year-old man is brought to the psychiatric clinic by his spouse. Over the past 3 weeks, the patient has slept only 2 hours per night, spoken at an unusually rapid pace, and claimed he is on the verge of single-handedly solving the global energy crisis. He also reports hearing the voices of angels who provide him with daily guidance. The spouse confirms this is his third episode of this nature in the past five years. Crucially, the spouse notes that even between these highly energetic episodes, during periods when the patient's mood is completely stable and normal for several months at a time, he continues to hear the angels' voices and firmly believes he possesses supernatural powers. A comprehensive medical and toxicological workup is negative. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Schizoaffective disorder

Answer

Schizoaffective disorder
The most likely diagnosis is schizoaffective disorder. This condition is defined by an uninterrupted period of illness during which there is a major mood episode (manic or depressive) concurrent with active-phase symptoms of schizophrenia (such as delusions or hallucinations). The crucial defining feature that separates it from a primary mood disorder with psychotic features is the timeline criterion: the patient must experience delusions or hallucinations for 2 or more weeks in the strict absence of a major mood episode. Because this patient continues to experience auditory hallucinations and delusions for several months while his mood is completely stable, he strictly meets the criteria for schizoaffective disorder.

Step-by-Step Solution

1
Identify the patient's clinical symptoms.
The patient exhibits signs of a manic episode (decreased need for sleep, rapid speech, grandiosity) as well as psychotic symptoms (auditory hallucinations, delusions).
Establishing the presence of both mood and psychotic domains is the first step in differentiating the diagnosis.
2
Determine the temporal relationship between the mood symptoms and the psychotic symptoms.
The psychotic symptoms persist for several months even when the patient's mood is completely stable (euthymic).
The timeline criterion (psychosis occurring in the absence of a mood episode for at least 2 weeks) is the definitive differentiator between a primary psychotic disorder and a mood disorder.
3
Select the diagnosis that perfectly matches this specific timeline pattern.
Schizoaffective disorder is the only condition characterized by prominent mood episodes accompanied by an underlying, independent psychotic illness.
Bipolar disorder with psychotic features would require the psychosis to resolve when the mania resolves.

Key Concept

Differentiating schizoaffective disorder from bipolar disorder with psychotic features based on the presence of psychotic symptoms during euthymic periods.
Question 1118Question →

A 47-year-old male executive seeks psychiatric evaluation for profound sadness, early morning awakening, and severe anhedonia that have progressively worsened over the past four months. His past medical history is unremarkable, and he is currently taking no medications. Arrange the following therapeutic steps in the exact sequence recommended by standard clinical guidelines for the progressive pharmacological and procedural management of major depressive disorder. Assume that each step is implemented sequentially only after the preceding intervention has yielded an inadequate clinical response (either non-response or insufficient partial response) despite optimal dosing and duration.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: initiate an SSRI, switch to an SNRI upon non-response, augment with an atypical antipsychotic or lithium upon partial response, and finally utilize ECT for established treatment-resistant depression.
The established clinical algorithm for the progressive management of major depressive disorder prioritizes sequential, stepped interventions to balance efficacy and tolerability. The foundation of treatment begins with an initial monotherapy trial of a first-line agent, most commonly an SSRI. If the patient exhibits non-response after an adequate duration (typically 4-8 weeks at a therapeutic dose), the standard next step is to switch to a different monotherapy, often of another class such as an SNRI or an NDRI (like bupropion). Should this second trial yield only a partial response, the addition of an augmentation agent—such as a second-generation antipsychotic (e.g., aripiprazole, quetiapine), lithium, or triiodothyronine (T3)—is recommended to optimize the existing response. Finally, if the patient continues to experience severe, treatment-resistant depression after multiple failed trials of different pharmacologic classes and augmentation strategies, non-pharmacologic neuromodulation, specifically electroconvulsive therapy (ECT), is indicated as the definitive next step.

Step-by-Step Solution

1
Determine the optimal initial treatment for the patient.
Select SSRI monotherapy.
The patient has a new, severe major depressive episode without prior treatment, making an SSRI the first-line standard of care.
2
Determine the next step following the failure of the initial monotherapy.
Switch to an alternative agent of a different class, such as an SNRI.
When a patient shows non-response to an adequate initial SSRI trial, clinical guidelines strongly recommend switching to another first-line agent, often from a different class.
3
Determine the management approach for an inadequate response to the second trial.
Augment the current therapy with an adjunctive agent like an atypical antipsychotic or lithium.
If the patient achieves only a partial response to the second antidepressant trial, augmentation is employed to boost efficacy rather than entirely abandoning the trial.
4
Identify the definitive approach for profound treatment resistance.
Refer for electroconvulsive therapy (ECT).
After the failure of multiple distinct medication trials involving different classes and augmentation, the patient meets criteria for treatment-resistant depression, making ECT highly appropriate and effective.

Key Concept

The stepped-care approach to treatment-resistant major depressive disorder requires a progressive escalation from SSRI monotherapy to switching medication classes, followed by augmentation strategies, and ultimately procedural interventions such as ECT.
Question 1119Question →

A 73-year-old retired architect is evaluated in the hospital for severe agitation. He was admitted 24 hours ago for cellulitis of the right lower extremity, for which wound cultures grew methicillin-resistant *Staphylococcus aureus* (MRSA). His medical history is significant for bipolar I disorder (not currently taking mood stabilizers), severe osteoarthritis (managed with scheduled tramadol), and a 3-year history of progressive cognitive decline, prominent visual hallucinations of small animals, and a resting tremor. He has a documented diagnosis of major neurocognitive disorder with Lewy bodies.

Currently, he is severely agitated, attempting to pull out his intravenous line, and striking at the nursing staff. He is unable to cooperate with a medical examination or verbal de-escalation. His husband, who is his legally appointed healthcare proxy, requests that the medical team administer medication to calm him down. However, the patient's daughter, who just arrived, demands that no mind-altering medications be given and suggests using physical restraints instead.

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Administer low-dose quetiapine with the husband's consent

Answer

The most appropriate next step is to administer low-dose quetiapine with the consent of the patient's husband.
The correct action is to administer low-dose quetiapine. This patient has major neurocognitive disorder with Lewy bodies (DLB) and is presenting with acute delirium secondary to an infection, resulting in dangerous agitation. In DLB, patients have a severe sensitivity to neuroleptics (antipsychotics with strong dopamine D2 receptor antagonism, such as haloperidol or risperidone), which can cause irreversible parkinsonism, impaired consciousness, and autonomic dysfunction. When non-pharmacological interventions fail and the patient poses an immediate danger to themselves or staff, the safest pharmacological options are low-dose quetiapine or clozapine, as they have the lowest D2 receptor affinity. Furthermore, the patient's husband is the legally appointed healthcare proxy; his consent for pharmacological treatment legally overrides the daughter's objections.

Step-by-Step Solution

1
Identify the primary diagnosis and current acute complication.
The patient has Dementia with Lewy Bodies (DLB) and is experiencing acute hyperactive delirium secondary to an MRSA infection.
Understanding the underlying neurocognitive disorder is essential, as DLB dictates specific pharmacological contraindications.
2
Evaluate the ethical conflict regarding consent for treatment.
The husband's consent for pharmacological treatment is legally binding.
The husband is the legally appointed healthcare proxy, meaning his medical decisions override the conflicting requests of the daughter.
3
Select the most appropriate and safe intervention for severe agitation in DLB.
Low-dose quetiapine is the treatment of choice.
Patients with DLB have severe neuroleptic sensitivity. Typical antipsychotics and most atypicals (like risperidone) can cause life-threatening parkinsonism. Quetiapine has low D2 receptor affinity and is safer.
4
Rule out contraindicated medications based on the patient's history and current medication list.
Avoid linezolid (risk of serotonin syndrome with tramadol) and SSRI monotherapy (risk of manic switch in bipolar I).
Comprehensive management requires checking for dangerous drug-drug interactions and psychiatric contraindications.

Key Concept

Management of severe agitation in Dementia with Lewy Bodies (DLB)
Estimated Time:2m 0s
Question 1120Question →

A 72-year-old woman is brought to the clinic by her son due to a 6-month history of progressive memory impairment, apathy, and severe psychomotor slowing. She frequently forgets conversations and has stopped participating in her usual social activities. She also reports worsening fatigue, constipation, and feeling cold constantly. Her medical history is significant for bipolar I disorder, which has been well-controlled on lithium monotherapy for 15 years, and hypertension. Current medications are lithium and lisinopril. Vital signs show a blood pressure of 130/80 mm Hg and a heart rate of 52/min. Physical examination reveals delayed relaxation of the deep tendon reflexes, dry skin, and a slightly puffy face. Cognitive assessment yields a Montreal Cognitive Assessment (MoCA) score of 19/30.

Laboratory results are as follows:

TestResultReference Range
Serum lithium0.8 mEq/L0.6-1.2 mEq/L
Thyroid-stimulating hormone (TSH)0.2 mIU/L0.4-4.0 mIU/L
Free thyroxine (T4)0.5 ng/dL0.9-1.7 ng/dL

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Magnetic resonance imaging of the brain

Answer

Magnetic resonance imaging of the brain
This patient presents with a major neurocognitive decline accompanied by classical signs of hypothyroidism (bradycardia, delayed deep tendon reflexes, constipation, cold intolerance). In the workup of a neurocognitive disorder, evaluating for reversible causes is mandatory. Her laboratory findings reveal a low free T4 level, confirming hypothyroidism. However, her thyroid-stimulating hormone (TSH) level is inappropriately low. In primary hypothyroidism, the lack of negative feedback from T4 leads to a dramatically elevated TSH. A low or inappropriately normal TSH in the setting of low free T4 indicates secondary (central) hypothyroidism, pointing to a failure of the pituitary gland or hypothalamus. The most common causes of central hypothyroidism are structural lesions, such as a pituitary macroadenoma, craniopharyngioma, or other compressive intracranial masses. Therefore, the most appropriate next step in management is a magnetic resonance imaging (MRI) scan of the brain to visualize the hypothalamic-pituitary axis.

Step-by-Step Solution

1
Identify the primary clinical syndrome.
The patient presents with reversible neurocognitive impairment (pseudodementia) accompanied by classic hypothyroid signs (bradycardia, delayed reflexes, cold intolerance, constipation).
Establishing the clinical phenotype is essential before interpreting laboratory values in the context of cognitive decline.
2
Interpret the thyroid function tests.
The free T4 is low (confirming hypothyroidism), but the TSH is inappropriately low (0.2 mIU/L), establishing a diagnosis of secondary (central) hypothyroidism.
Differentiating primary (high TSH) from secondary (low/normal TSH) hypothyroidism determines the anatomic location of the defect.
3
Differentiate the etiology from medication adverse effects.
Lithium induces primary hypothyroidism by inhibiting thyroid hormone release, which would elevate TSH. The patient's low TSH pattern rules out lithium-induced thyroid dysfunction.
Ruling out medication-induced effects prevents inappropriate cessation of a stable, long-term psychiatric regimen.
4
Determine the appropriate diagnostic intervention for central hypothyroidism.
Magnetic resonance imaging (MRI) of the brain is required.
Central hypothyroidism is most frequently caused by structural compressive lesions in the hypothalamic-pituitary axis (e.g., macroadenoma), which must be visualized radiographically.

Key Concept

Reversible neurocognitive impairment can be caused by central hypothyroidism (characterized by low free T4 and an inappropriately low TSH), which requires an MRI of the brain to evaluate for a pituitary or hypothalamic mass, independent of chronic lithium therapy which typically causes primary hypothyroidism (high TSH).
PreviousPage 56 / 414Next